Ascentage Pharma Group Intl ADR (AAPG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AAPG | CLDX | GRAL | ||
| Company | Ascentage Pharma Group Intl ADR | Celldex Therapeutics | Grail Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 22.83 | 32.73 | 51.41 | ||
| High | 22.83 | 33.04 | 51.63 | ||
| Low | 22.20 | 31.65 | 49.15 | ||
| Latest | 22.20 | 31.94 | 50.34 | ||
| Change | -0.80 | -1.29 | -1.86 | ||
| % Change | -3.48% | -3.88% | -3.56% | ||
| Volume | 4,717 | 353,709 | 355,650 | ||
| 20-Day Average Volume | 3,321 | 1,166,509 | 718,849 | ||
| Previous Close | 23.00 | 33.23 | 52.20 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 25.54 | 32.99 | 50.99 | ||
| 20-Day Raw Stochastic | 0.00% | 46.14% | 47.04% | ||
| 20-Day Relative Strength | 42.08 | 50.74 | 44.28 | ||
| Weighted Alpha | -26.14 | +37.77 | +71.59 | ||
| Today's Opinion | 88% Sell | 80% Buy | 80% Sell | ||
| Previous Opinion | 80% Sell | 100% Buy | 64% Sell | ||
| Last Month's Opinion | 88% Sell | 88% Buy | 72% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -11.66% since 04/22/26 | -7.00% since 04/22/26 | -5.67% since 04/22/26 | ||
| Low | 22.20 on 04/29/26 | 31.65 on 04/29/26 | 49.15 on 04/29/26 | ||
| High | 23.95 on 04/24/26 | 34.96 on 04/23/26 | 55.88 on 04/27/26 | ||
| 1-Month | |||||
| %Chg | -3.65% since 03/27/26 | +5.00% since 03/27/26 | +2.33% since 03/27/26 | ||
| Low | 22.20 on 04/29/26 | 28.41 on 04/02/26 | 44.06 on 04/10/26 | ||
| High | 28.06 on 04/06/26 | 35.79 on 04/20/26 | 55.88 on 04/27/26 | ||
| 3-Month | |||||
| %Chg | -11.20% since 01/29/26 | +28.86% since 01/29/26 | -50.86% since 01/29/26 | ||
| Low | 19.11 on 03/20/26 | 22.33 on 02/06/26 | 41.50 on 02/23/26 | ||
| High | 28.06 on 04/06/26 | 35.79 on 04/20/26 | 109.35 on 02/03/26 | ||
| 6-Month | |||||
| %Chg | -33.53% since 10/29/25 | +22.41% since 10/29/25 | -41.77% since 10/29/25 | ||
| Low | 19.11 on 03/20/26 | 22.10 on 11/11/25 | 41.50 on 02/23/26 | ||
| High | 34.50 on 11/14/25 | 35.79 on 04/20/26 | 118.84 on 01/22/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,146,613 | 2,211,988 | 2,141,244 | ||
| Shares Outstanding, K | 93,331 | 66,566 | 41,020 | ||
| Annual Sales | 82,100,000 | 1,550,000 | 147,170,000 | ||
| Annual Net Income | -177,710,000 | -258,760,000 | -408,350,000 | ||
| Last Quarter Sales | N/A | 120,000 | 43,600,000 | ||
| Last Quarter Net Income | N/A | -81,320,000 | -99,180,000 | ||
| 60-Month Beta | 0.79 | 1.19 | 4.62 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -1.22 on 02/25/26 | -2.44 on 02/19/26 | ||
| Earnings Date | 03/25/26 | 05/14/26 | 05/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||